Category: 3. Business

  • South Korean banks take the lead to bridge gender inequalities

    South Korean banks take the lead to bridge gender inequalities

    MJ Song, a South Korean working mother with a four-year-old son, considers herself lucky because she has been able to work for one company for more than 15 years without her career being hindered by starting a family.

    Her employer, a unit of Shinhan Financial Group, offers generous pay and benefits such as baby bonuses, childcare allowances and flexible working, allowing her to balance work and family life in a country notorious for long working hours and rigid corporate cultures.

    Song took two years of maternity leave after her son was born then worked for four hours a day for a year, receiving half her normal salary. Shinhan also allows women to work two hours fewer a day during pregnancy and employees with children in their first two years of primary school to start work an hour later.

    “I am satisfied with my job as the salary is high with a lot of benefits for working moms,” says Song. “The workload is heavy, but my PC gets automatically turned off after 6pm. It has been relatively easy to balance work and family life, while most of my friends have quit their jobs after childbirth.”

    Korean financial groups have been one of the most coveted workplaces among female graduates, thanks to their competitive pay and childcare-related perks, despite technology causing wider cuts to the industry’s workforce.

    Financial groups are also notable for their relatively high number of female workers in the male-dominated, manufacturing-driven economy. Female workers account for more than half of the financial sector workforce, about double the average in South Korea’s 500 biggest companies by sales, according to research group Leaders Index.

    Labour expert Bae Kyu-shik says: “Financial companies have become good employers for women, thanks to their high pay and strong internal welfare benefits.”

    Some content could not load. Check your internet connection or browser settings.

    Women boast an average 14.5 years of service at Korean banks versus men’s 15.4 years, while women’s annual salaries average Won96.9mn ($66,100), compared with Won128.4mn for men, Leaders Index data shows. Similar to the manufacturing sector, most Korean bank staff retire in their mid-fifties, but they usually receive generous severance pay and packages that amount to several years’ salary if they retire early.

    Foreign lenders in Korea, such as Citibank and Standard Chartered, also offer flexible work for parents with young children, reduced hours for pregnant women and longer paternity leave. They also offer baby bonuses, although these are less generous than those from local counterparts.

    As the country addresses the world’s lowest fertility rate of 0.75 per cent, Korean banks have been at the forefront of the government-led initiative to solve it by offering various childcare benefits. The demographic crisis poses a huge challenge for sustaining economic growth and providing pensions and healthcare for an ageing population.

    But economic and cultural discrimination means many Korean women remain reluctant to marry and have children. South Korea has the highest gender pay gap among rich countries, with women paid almost a third less than men, despite their above-average level of tertiary education, reports the OECD.

    South Korea’s male-oriented corporate culture and working hours — some of the longest in the OECD — remain a barrier to women’s labour participation, with more than 15 per cent of married women quitting jobs after having children, according to government data, while those who keep working struggle to progress in their careers.

    The government has been spending heavily to counter the low birth rate, with financial groups going beyond national requirements by offering baby bonuses worth tens of thousands of dollars and up to three years of maternity leave, as well as flexible working for parents with children aged below 10 at school. Statutory leave is up to a year and a half.

    Banks such as KB Kookmin and Woori last year started offering up to three years of “parental resignation” programmes for employees with children aged below seven, on top of a two-year childcare leave, with the guarantee of returning to the same position.

    There are limits, however. Despite the government policy to support paternity leave — a father with a child under eight can take up to a year and a half off — men taking the leave remains at a single-digit rate at most banks because of social norms that still regard childcare and household duties as a woman’s job.

    Some content could not load. Check your internet connection or browser settings.

    Despite the high proportion of female workers, few are at executive level in the financial sector, as most women work in retail banking, rather than higher-margin businesses such as corporate and investment banking, which are seen as better for promotions.

    “There are equal opportunities for hiring, but they are not equal positions,” says Park Ju-geun, head of Leaders Index, noting there is still a 30 per cent pay gap in banking. “Women still don’t have many opportunities for promotions as they are barred from key operations like strategic planning, sales, marketing and treasury departments.”

    The number of female executives is increasing after legislation in 2022 banned single-gender boards at companies with assets of more than Won2tn. But women still hold only 12.7 per cent of executive positions at South Korean banks, although this is higher than the 8.1 per cent average across the country’s 500 biggest companies, according to Leaders Index.

    There are signs of improvement, however. Internet-only lender Toss Bank and the South Korean unit of Citibank both have female chief executives, while some banks offer leadership and mentoring programmes for women.

    “Women are often hired for supplementary positions, so most fail to move up the ladder,” says Oh Hee-jung, deputy head of the Korean Finance & Service Workers’ Union. “Like in other sectors, the glass ceiling still exists in the financial sector, with most women struggling to shatter it.”

    Continue Reading

  • Chinese manufacturers’ shift to flexibility leaves gig labourers exposed

    Chinese manufacturers’ shift to flexibility leaves gig labourers exposed

    Every morning, Zhou sifts his way through the crowds of hopeful workers, factory owners and snake oil sellers that throng the open air labour market in Datang, Guangzhou in the hope of finding suitable work.

    Wading into a crowd of hopefuls surrounding a clothing factory manager perched on a bicycle one day last month, he picks up the half-finished lace top on display, weighs it in his hands and shakes his head: the pay per item is too low for a work that intricate.

    Zhou, who declined to give a full name, is one of at least 200mn people in China working in the “gig economy”, a growing, informal sector of the labour market that spans everything from delivery drivers to construction workers. And while China’s fast fashion industry has long relied on nimble day labourers like Zhou, analysts say the increasing use of short-term labour in manufacturing is harming the country’s human capital and putting workers at risk.

    “We’re a new generation of workers with a new generation of thinking,” says Zhou, a wiry and moustachioed worker in his 30s who moved to the garment production hub of Guangzhou eight years ago from the central province of Hubei. Although more flexible, he ends up working 12 hours a day, often seven days a week. “We wake up, work, finish work, sleep: it’s a two-point line.”

    Officially, Chinese companies are only supposed to employ a maximum 10 per cent of their staff on a short-term basis. But analysts say that in recent years, the proportion of temporary workers in the manufacturing sector has crept up, making life more precarious for a huge swath of the workforce and undermining labourers’ ability to learn new skills.

    Textile workshop in Datang. Analysts say that in recent years, the proportion of short-term workers in the manufacturing sector has crept up © Qilai Shen/Bloomberg

    For instance, a study by Peking University academic Zhang Dandan estimated that there were approximately 40mn short-term workers in the manufacturing sector by 2024, or about 31 per cent of the total. Previous surveys from five provinces suggested that the proportion of flexible workers was 20 per cent in 2017, after exhibiting a “significant upward trend” in the previous seven years, she wrote.

    Many Chinese factory workers are employed in long-term, full-time roles and sometimes remain at individual factories for decades. Under such conditions, they are entitled to workplace and health insurance, protection from unfair dismissal, a degree of training and, after a certain period of service, retirement and other benefits.

    Hiring temporary workers, either through contract labour agencies or via open air markets such as the one in Datang, can give factory managers more flexibility and lower costs by reducing payments for training and other benefits. For workers, it can mean greater choice over where to work and, in the short term, higher pay, as many receive bonuses for completing stints at each plant.

    But it also leaves them exposed. Most day workers and many agency labourers do not have contracts or workplace insurance and are clustered in the most low-skilled part of the production process, such as the final assembly of electronics.

    Analysts warn that the funnelling of large numbers of workers into tedious jobs that offer little chance of training or career advancement could create a skills deficit in the future and impede social mobility.

    “Contract labour becomes this very convenient way of just having this flexibility without the risk of any long-term commitments, without the risks of paying compensation, or the difficulties of firing people,” says Dmitri Kessler, founder of the Economic Rights Institute.

    Kessler says that using short-term labourers in electronics manufacturing also allows factories quickly to replace workers hurt when performing physically arduous tasks or exposed to harmful activities. “From our perspective, it’s extremely problematic,” he says.

    31%

    Estimated share of short-term workers in manufacturing sector by 2024

    Moreover, because hourly wages for temporary roles are often higher than for fixed work — though still cost the employer less given reduced additional benefits — many workers end up opting for short-term roles with little prospect of advancement and do not care about the companies they work for.

    “You develop a kind of a dependence on the most base level of employment . . . that has an impact on the productivity of the workers themselves,” says Kessler.

    Jenny Chan, a sociologist at the Hong Kong Polytechnic University, says that some factories can employ as many as 70 per cent of their workers on a temporary basis during peak seasons, although an absolute number is difficult to pin down. “This is definitely a more precarious, very fluid form of labour,” she says.

    The proportion of workers employed on a temporary basis has increased since about 2008, following both the global financial crisis and China’s introduction of a stricter labour law that offers greater protections to full-time workers, she says.

    As the growing usage started to attract greater government scrutiny, some factories turned to the country’s network of vocational schools to send trainees or interns to meet their staffing needs. Renewed scrutiny of the use of vulnerable student workers has only pushed the practice underground, she says. “They have been continuing the practice . . . they just made it more difficult to identify.”

    Mo, a temporary garment factory worker in his 30s who declined to give a full name, says he went through a variety of short-term roles in the services sector before arriving in the Datang garment manufacturing district to find work.

    Nowadays, he adds, outside of the most skilled jobs, lots of employment in China is offered on a flexible basis.

    “You just make yourself OK from one day to the next. But if you want to get married, have a family, you definitely can’t think like this,” Mo says of his life as a day labourer while he peruses yellow posters advertising roles in Datang. “Doing this kind of work is a rotten state of affairs.”

    Continue Reading

  • Mazdutide 9 mg Achieves Up to 20.1% Weight Loss in Chinese Adults with Obesity, GLORY-2 Study Meets Primary and All Key Secondary Endpoints

    SAN FRANCISCO and SUZHOU, China, Nov. 19, 2025 /PRNewswire/ — Innovent Biologics, Inc. (“Innovent”) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncologic, autoimmune, cardiovascular and metabolic, and ophthalmologic diseases, announces that the Phase 3 clinical trial of mazdutide, a first-in-class dual glucagon (GCG)/glucagon-like peptide-1 (GLP-1) receptor agonist, in Chinese adults with obesity (GLORY-2) met the primary endpoints and all key secondary endpoints. Innovent plans to submit the new drug application (NDA) of mazdutide 9 mg for weight management to the Center for Drug Evaluation (CDE) of China’s National Medical Products Administration (NMPA) in the near term.

    GLORY-2 (NCT06164873) is a Phase 3 clinical study to evaluate the efficacy and safety of mazdutide 9 mg combined with lifestyle intervention versus placebo in Chinese adults with obesity (BMI ≥30 kg/m²). The study enrolled 462 participants (including 16% with type 2 diabetes), randomized in a 2:1 ratio to receive mazdutide 9 mg group or placebo in the 60-week double-blind treatment period (mean baseline weight: 94.0 kg; mean BMI: 34.3 kg/m²).

    During the treatment period, participants in the mazdutide group exhibited continuous weight loss, with no plateau observed in Week 60. At Week 60, the mazdutide 9 mg group achieved a mean weight reduction of 18.55%, compared to 3.02% in the placebo group. 44.0% of participants in the mazdutide 9 mg group achieved a weight reduction of 20% or more, versus 2.6% in the placebo group (P<0.0001 for all comparisons). The key secondary endpoints demonstrated that among participants without type 2 diabetes, the mazdutide 9 mg group showed a mean weight reduction of 20.08% at Week 60 (placebo: 2.81%), with 48.7% of participants achieving a weight reduction of 20% or more (placebo: 3.1%; P<0.0001).

    Furthermore, all key secondary endpoints of the study were met, including other body weight endpoints, waist circumference, systolic blood pressure, triglycerides, non-HDL cholesterol, LDL cholesterol, and serum uric acid levels. Mazdutide 9 mg demonstrated superiority to placebo in all the above weight-loss and cardiometabolic endpoints.

    This study also evaluated liver fat content using MRI-PDFF in a subset of participants. Among participants (without type 2 diabetes) with baseline liver fat content ≥10%, the mean percent change in liver fat content from baseline to week 60 was -71.9% in the mazdutide 9 mg group compared with 5.1% in the placebo group.

    Mazdutide 9 mg demonstrated favorable tolerability and safety profiles, with no new safety signals identified. The majority of gastrointestinal adverse events were mild to moderate in severity and transient in nature. The proportion of participants who discontinued treatment prematurely due to adverse events was 2.9% in the mazdutide 9 mg group and 0% in the placebo group.

    Professor Linong Ji, the leading principal investigator of the study, Peking University People’s Hospital, stated, “As a chronic disease with a complex etiology, obesity requires public awareness of long-term treatment and management. China faces a high prevalence of obesity, with obese individuals bearing a significant burden of cardiometabolic diseases. Those with a BMI exceeding 32.5 kg/m², often experience an even greater cardiometabolic burden. This patient population requires special attention in clinical weight management and metabolic syndrome prevention. According to current Chinese clinical guidelines, metabolic surgery is often considered a first-line treatment for such patients. Extensive clinical evidence on GLP-1 receptor agonists demonstrates that the weight-loss efficacy of these drugs is dose-dependent. Therefore, developing pharmacological treatments tailored to moderate-to-severe obesity could offer new therapeutic options for this group. The investigators of this study and I are delighted that this study met both its primary endpoints and all key secondary endpoints. Mazdutide 9 mg has once again demonstrated outstanding weight-loss efficacy, multiple metabolic benefits and favorable safety. We hope mazdutide 9 mg will successfully achieve regulatory approval, supporting stratified weight management for China’s obese population and enabling more personalized treatment approaches.”

    Dr. Lei Qian, Chief R&D Officer of General Biomedicine of Innovent, stated, “Mazdutide 9 mg is currently the only GLP-1 receptor agonist that achieves over 20% weight loss in obese adults without T2D after 1 year of treatment with just a 2-step dose titration. Its development provides evidence-based medical support for effective weight management in Chinese patients with moderate-to-severe obesity, offering an alternative to metabolic surgery. We plan to submit a supplemental application for mazdutide 9 mg in the near future, aiming to deliver this innovative treatment to patients as soon as possible. Concurrently, the lifecycle management plan for mazdutide continues to expand its boundaries, exploring further therapeutic potentials. We are developing mazdutide for other indications on the basis of scientific evidence and unmet medical needs. Innovent will continue to strategically build our next-generation product pipeline in the cardiovascular and metabolic (CVM) field, and help people’s pursuit of a healthy life.”

    Mazdutide has earned widespread recognition supported by robust data set. Its Phase 2 clinical trial in Chinese subjects with overweight or obesity was selected by Nature Communications as one of the 50 most important studies in translational and clinical research and highlighted as Editor’s Choice. Additionally, mazdutide was listed among the “Top 10 Most Anticipated Drug Launches of 2025” by the FIERCE Pharma.

    Furthermore, clinical findings on mazdutide have been featured in top-tier international journals such as The New England Journal of Medicine, Nature Communications, Diabetes Care, and eClinicalMedicine, as well as presented at leading scientific conferences including the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) annual meetings. Notably, mazdutide is the first innovative drug in China’s endocrinology and metabolism field to have clinical results published in The New England Journal of Medicine, underscoring its significant clinical value.

    About Mazdutide

    Innovent entered into an exclusive license agreement with Eli Lilly and Company (Lilly) for the development and potential commercialization of mazdutide, a dual GCG/GLP-1 receptor agonist, in China. As a mammalian oxyntomodulin (OXM) analogue, in addition to the effects of GLP-1 receptor agonists on promoting insulin secretion, lowering blood glucose and reducing body weight, mazdutide may also increase energy expenditure and improve hepatic fat metabolism through the activation of glucagon receptor. Mazdutide has demonstrated excellent weight loss and glucose-lowering effects in clinical studies, as well as reducing waist circumference, blood lipids, blood pressure, serum uric acid, liver enzymes, liver fat content and improved insulin sensitivity.

    Innovent has currently conducted or completed seven Phase 3 clinical studies of mazdutide, including:

    • GLORY-1: A Phase 3 clinical study conducted in Chinese adults with overweight of obesity;
    • GLORY-2: A Phase 3 clinical study conducted in Chinese adults with moderately to severely obesity;
    • DREAMS-1: A Phase 3 clinical study conducted in Chinese adults with untreated type 2 diabetes;
    • DREAMS-2: A Phase 3 clinical study comparing mazdutide versus dulaglutide in Chinese adults with type 2 diabetes who have poor glycemia control with oral medication;
    • DREAMS-3: A Phase 3 clinical study comparing mazdutide versus semaglutide in Chinese adults with type 2 diabetes and obesity;
    • GLORY-3: A Phase 3 clinical study comparing mazdutide versus semaglutide 2.4mg in Chinese adults with overweight of obesity accompanied metabolic-associated fatty liver disease (MAFLD);
    • GLORY-OSA: A Phase 3 trial in Chinese participants with obstructive sleep apnea (OSA) and obesity;

    Among these, the first five Phase 3 clinical studies have all met their primary endpoints, while the remaining two Phase 3 studies are still ongoing.

    In addition, several clinical studies of mazdutide are ongoing in adolescents with obesity, patients with metabolic dysfunction-associated steatohepatitis (MASH),heart failure with preserved ejection fraction (HFpEF) etc.

    Mazdutide has received NMPA approval for two indications:

    First Indication: As an adjunct to a reduced-calorie diet and increased physical activity for chronic weight management in adult patients with an initial Body Mass Index (BMI) of:

    • BMI ≥ 28 kg/m² (obesity); or
    • BMI ≥ 24 kg/m² (overweight) in the presence of at least one weight-related comorbid condition (e.g., hyperglycemia, hypertension, dyslipidemia, fatty liver, or obstructive sleep apnea syndrome).

    Second Indication: For glycemic control in adults with type 2 diabetes.

    Monotherapy:

    For adults with type 2 diabetes who have inadequate glycemic control despite diet and exercise interventions.

    Combination Therapy:

    For adults with T2D who still have poor glycemic control despite:

    • Diet and exercise, plus Metformin and/or sulfonylureas;
    • Diet and exercise, plus Metformin and/or SGLT2 inhibitors (SGLT2i).

    About Innovent Biologics

    Innovent is a leading biopharmaceutical company founded in 2011 with the mission to empower patients worldwide with affordable, high-quality biopharmaceuticals. The company discovers, develops, manufactures and commercializes innovative medicines that target some of the most intractable diseases. Its pioneering therapies treat cancer, cardiovascular and metabolic, autoimmune and eye diseases. Innovent has launched 16 products in the market. It has 2 new drug applications under regulatory review, 4 assets in Phase 3 or pivotal clinical trials and 15 more molecules in early clinical stage. Innovent partners with over 30 global healthcare companies, including Eli Lilly, Roche, Takeda, Sanofi, Incyte, LG Chem and MD Anderson Cancer Center.

    Guided by the motto, “Start with Integrity, Succeed through Action” Innovent maintains the highest standard of industry practices and works collaboratively to advance the biopharmaceutical industry so that first-rate pharmaceutical drugs can become widely accessible. For more information, visit www.innoventbio.com, or follow Innovent on Facebook and LinkedIn.

    Statement: Innovent does not recommend the use of any unapproved drug (s)/indication (s).

    Forward-looking statement

    This news release may contain certain forward-looking statements that are, by their nature, subject to significant risks and uncertainties. The words “anticipate”, “believe”, “estimate”, “expect”, “intend” and similar expressions, as they relate to Innovent, are intended to identify certain of such forward-looking statements. Innovent does not intend to update these forward-looking statements regularly.

    These forward-looking statements are based on the existing beliefs, assumptions, expectations, estimates, projections and understandings of the management of Innovent with respect to future events at the time these statements are made. These statements are not a guarantee of future developments and are subject to risks, uncertainties and other factors, some of which are beyond Innovent’s control and are difficult to predict. Consequently, actual results may differ materially from information contained in the forward-looking statements as a result of future changes or developments in our business, Innovent’s competitive environment and political, economic, legal and social conditions.

    Innovent, the Directors and the employees of Innovent assume (a) no obligation to correct or update the forward-looking statements contained in this site; and (b) no liability in the event that any of the forward-looking statements does not materialize or turn out to be incorrect.

    SOURCE Innovent Biologics

    Continue Reading

  • Lenovo Delivers Record Quarterly Results, Marking Significant Progress in Hybrid AI

    Lenovo Delivers Record Quarterly Results, Marking Significant Progress in Hybrid AI

    November 20, 2025 – Lenovo Group Limited (HKSE: 992) (ADR: LNVGY), together with its subsidiaries (‘the Group’), today reported record results for the second quarter of fiscal year 2025/26, with overall group revenue reaching an all-time high of US$20.5 billion, up 15% year-on-year. Adjusted net income[1] grew 25% year-on-year to US$512 million, and adjusted net income margin expanded to 2.5%, driven by higher revenues. Together, these reflect the strength of the Group’s operational performance as they exclude the impact of non-cash fair value loss on warrants, notional interest on convertible bonds, and other non-cash items.

    The Group delivered double-digit year-on-year revenue growth across all main business groups and sales geographies. The AI-related revenue mix increased by 13 percentage points year-on-year, accounting for 30% of the Group’s total revenue this quarter. The growth was driven by high-double-digit revenue growth in AI Servers and triple-digit revenue growth in AI PCs, AI smartphones, and AI Services.

    These results are a testament to the Group’s clear strategy, operational excellence, and relentless innovation, reflecting not only the strength of its business today but also the resilience of its unique ‘Global/Local’ model and the vision of a company built to lead in the AI era. With the initial wave of infrastructure build-out in the AI era, the trend is evolving toward a more human- and enterprise-centric phase, as large language models become commoditized and user priorities shift toward personalization and private domain. This evolution is unlocking new opportunities across devices, hybrid infrastructure, and tailored solutions, and enabling the Group to expand its leadership in Personal AI and further deliver its value proposition in Enterprise AI.

    As the macroeconomic environment stabilizes, Lenovo remains committed to executing its Hybrid AI strategy and investing in innovation to deliver sustainable long-term returns to shareholders and make AI truly personalized.

    Lenovo’s Board of Directors declared an interim dividend of 8.50 HK cents per share.

    Chairman and CEO quote – Yuanqing Yang:

    “Capitalizing on the AI democratization trend, and thanks to our clear strategy, operational excellence and relentless innovation, Lenovo delivered another quarter of record performance, while making important progress in both Personal AI and Enterprise AI. We will continue to leverage our unique Global/Local model to navigate uncertainties and capture the tremendous Hybrid AI opportunities, and in doing so not only deliver sustainable long-term returns to our shareholders, but also make AI truly personalized for every individual and every enterprise.”

    Financial Highlights:

    Personal AI: Innovation strengthened market leadership, enriching ecosystem

    Lenovo is meeting growing consumer demand for hyper-personalization with its Personal AI strategy, ‘One Personal AI, Multiple Devices’. Launching globally at Tech World on January 6, 2026, Lenovo’s Personal AI super agent will seamlessly orchestrate across wearable and ambient devices to perceive, learn, and act like its user – ultimately becoming a true Personal AI Twin.

     Intelligent Devices Group (IDG) as the core engine for Lenovo’s Personal AI strategy, delivered strong Q2 FY25/26 results:

    • Overall IDG revenue grew nearly 12% year-on-year to US$15.1
    • PC market leadership was strengthened with a record 25.6% market share, further widening the lead over the number two player.
    • The PCs and smart devices business maintained its industry-leading profitability, driven by solid performance from high-margin segments.
    • AI PC penetration accelerated, accounting for 33% of all Lenovo PC shipments. Lenovo ranks #1 globally in the Windows AI PC segment with a 31.1% market share. Motorola smartphones delivered record volumes.
    • AI device momentum is particularly encouraging, with revenue mix from AI devices up 17 points year-on-year to 36%.

    Enterprise AI: Unleashing Hybrid AI Advantage, from infrastructure to solutions and services

    Lenovo is advancing its Enterprise AI strategy to help customers turn data and knowledge into actionable insights and value. The Group is well-positioned to drive Enterprise AI transformation and develop an AI Twin for customers. The shift from cloud-based AI training to on-premises and edge inferencing is expected to fuel greater growth in AI devices and AI applications, further expanding the company’s total addressable market.

     Infrastructure Solutions Group (ISG) as the key driver of Lenovo’s hybrid infrastructure, delivered strong growth in Q2 FY25/26:

    • Revenue grew 24% year-on-year to US$4.1 billion through the continued strong execution of its CSP (Cloud Service Provider) and Enterprise SMB dual strategy.
    • CSP business delivered record fiscal Q2 revenue.
    • The AI infrastructure business revenue achieved high double-digit year-on-year growth with a strong
    • Revenue from industry-leading liquid cooling solutions grew 154% year-on-year.
    • By optimizing Enterprise SMB business models to better serve the distinct needs of enterprise and SMB customers, the Group is confident that the infrastructure business will return to profitable growth soon.

     Solutions and Services Group (SSG) delivered solid growth in Q2 FY25/26, providing solutions and services for enterprises that leverage the Lenovo Hybrid AI Advantage:

    • SSG’s overall revenue grew 18% year-on-year to US$2.6 billion – marking 18 consecutive quarters of year-on-year revenue growth.
    • Operating margin was up 1.9 points year-on-year to over 22%.
    • Revenue from Support Services accelerated with double-digit year-on-year growth; Managed services and Projects and Solutions revenue mix was up 1 point year-on-year to almost 60% of SSG’s total revenue.
    • SSG is unleashing the power of Lenovo Hybrid AI Advantage, combining the AI factory, AI services, and the AI library of repeatable, scalable AI solutions for selected vertical industries and horizontal functions.

    Corporate and ESG highlights

    Achievements, announcements, and notable commitments over the past quarter include:

    [1] Note on adjusted net income:Adjusted measure was defined as financial metric by excluding net fair value changes on financial assets at fair value through profit or loss, amortization of intangible assets resulting from mergers and acquisitions, impairment and write-off of intangible assets, dilution gain on interest in an associate, fair value change on derivative financial liabilities relating to warrants, and notional interest on convertible bonds; and the corresponding income tax effects, if any.

    About Lenovo

    Lenovo is a US$69 billion revenue global technology powerhouse, ranked #196 in the Fortune Global 500, and serving millions of customers every day in 180 markets. Focused on a bold vision to deliver Smarter Technology for All, Lenovo has built on its success as the world’s largest PC company with a full-stack portfolio of AI-enabled, AI-ready, and AI-optimized devices (PCs, workstations, smartphones, tablets), infrastructure (server, storage, edge, high performance computing and software defined infrastructure), software, solutions, and services. Lenovo’s continued investment in world-changing innovation is building a more equitable, trustworthy, and smarter future for everyone, everywhere. Lenovo is listed on the Hong Kong stock exchange under Lenovo Group Limited (HKSE: 992) (ADR: LNVGY). To find out more visit https://www.lenovo.com, and read about the latest news via our StoryHub. 

    Continue Reading

  • Asana Launches Asana Gov, a Secure Platform for Delivering Mission-Critical Programs • Asana, Inc.

    Asana Launches Asana Gov, a Secure Platform for Delivering Mission-Critical Programs • Asana, Inc.

    Purpose-built work management platform to help agencies manage complex programs, meet compliance standards, and collaborate across teams securely

    SAN FRANCISCO–(BUSINESS WIRE)–Nov. 19, 2025–
    Asana, Inc. (NYSE: ASAN), a leading work management platform for human + AI collaboration, today announced Asana Gov, a FedRAMP-in-process platform designed to help government agencies, regulated industries, and public sector partners plan, execute, and collaborate on mission-critical work with clarity and accountability – while meeting strict federal security and compliance standards.

    The stakes in government work are high—measured in mission success and public trust. Yet many agencies still rely on siloed data, manual workflows, and legacy systems that slow program execution and make collaboration harder. Asana Gov connects teams, tools, and mission objectives in one secure workspace—breaking down silos, driving change, and making it easy to execute on mandates securely and in compliance with federal standards.

    How Asana Gov Supports Mission-Critical Work

    Designed for government organizations with multiple departments and programs, Asana Gov uses the Asana Work Graph® to map who is doing what work, by when, how, and why—giving teams a clear, connected view of work and ownership across initiatives. With this context, agencies can:

    • Turn goals into action: Connect all work to strategic goals with clear owners, timelines, and progress tracking, so teams can see how their efforts ladder up across departments and programs.

    • Enable cross-department execution: Manage work across agency teams, such as through work intake and program management, across departments and delivery teams in one secure workspace built for collaboration and compliance.

    • Respond quickly to change: Adapt to new mandates, leadership shifts, or evolving needs with real-time dashboards and AI-powered updates that surface progress, risks, and dependencies—so teams can stay aligned and keep programs on track.

    “Government work is among the most consequential in the world, yet the tools public servants rely on often slow them down,” said Arnab Bose, Chief Product Officer at Asana. “Asana Gov is built to remove that barrier. It empowers teams to not just manage work, but to execute on their mission with the clarity, speed, and security today’s public sector demands. When we free public servants from administrative complexity, they can focus on what truly matters: serving the public.”

    Built for Secure, Scalable Collaboration

    Asana Gov is built to meet federal security standards and is targeted to operate in a FedRAMP Moderate environment (currently designated “In Process”). Cloud-based and quick to deploy, it helps agencies plan, track, and report on work with shared visibility and built-in safeguards such as role-based access controls, audit trails, and multi-factor authentication. Teams can start small—with a single workflow or project—and expand securely across departments and programs as adoption and use cases grow.

    Expert Perspectives

    “The hardest part of innovation in government isn’t always technology—it’s getting buy-in across leadership, IT, and program offices. A FedRAMP-compliant, easy-to-use platform like Asana Gov bridges that divide. It gives IT leaders the security they need while giving employees a tool they’ll actually adopt, turning modernization from aspiration into measurable progress.”

    Jacques Newgen, Chief Service Delivery Officer of Definitive Innovative Solutions; Founder and CEO of Fluidity Concepts LLC.

    “Modern government isn’t just about doing the work—it’s about building public trust. When work, goals, and outcomes are visible in one place like Asana, it empowers every government employee to tell the story of how their day-to-day work delivers for citizens and society.”

    Paul Kruchoski, Director, Guidehouse.

    Availability

    Asana Gov is expected to be available beginning mid-December 2025 to U.S. federal, state, and local government agencies, as well as government contractors, education institutions, and global organizations in regulated industries. It’s listed on the FedRAMP Marketplace as “In Process” and is expected to be available via GSA Schedule contracts through partners including Carahsoft. In addition to platform licenses, rollout support and flexible plans tailored to government needs will be available. To learn more or request access for your agency or organization, visit asana.com/product/asana-gov.

    About Asana

    Asana is a leading work management platform for human + AI collaboration. Over 170,000 customers like Accenture, Amazon, Anthropic and Suzuki rely on Asana to align teams and accelerate organizational impact. Whether it’s managing strategic initiatives, cross-functional programs, or company-wide goals, Asana helps organizations bring clarity to complexity—turning plans into action with AI working alongside teams every step of the way. To learn more, visit www.asana.com.

    Press Inquiries:
    Claire Cameron-Johnson
    press@asana.com

    Source: Asana, Inc.

    Continue Reading

  • Nvidia shares jump after revenue and outlook beat estimates

    Nvidia shares jump after revenue and outlook beat estimates

    Danielle KayeBusiness reporter

    Reuters Jensen is wearing a black leather jacket. He is gesturing with both hands while standing next to a large, computer server or data centre hardware on a dark stage. The equipment features metallic panels and visible internal components, suggesting advanced computing technology.Reuters

    Chief executive Jensen Huang said sales for some of Nvidia’s AI components were “off the charts”

    Chip giant Nvidia beat Wall Street’s expectations for revenue and upcoming sales, easing investor concerns about heavy artificial intelligence (AI) spending that have unsettled markets.

    In its quarterly earnings report on Wednesday, the firm said revenue for the three months to October jumped 62% to $57bn, driven by demand for its chips used in AI data centres. Sales from that division rose 66% to more than $51bn.

    Fourth-quarter sales forecasts in the range of $65bn also topped estimates, sending shares in Nvidia about 4% higher in after-hours trading.

    Nvidia, the world’s most valuable company, is seen as a bellwether for the AI boom. The chip-maker’s results could inform market sentiment.

    Chief executive Jensen Huang said in a statement that sales of its AI Blackwell systems were “off the charts” and that “cloud GPUs [graphics processing units] are sold out”.

    “There’s been a lot of talk about an AI bubble. From our vantage point, we see something very different,” he said, on a call with analysts.

    “We excel at every phase of AI.”

    The chip-maker’s quarterly report garnered even more attention than usual on Wall Street amid mounting concern that AI stocks are overvalued – fears that may persist despite Nvidia’s blockbuster results.

    Those fears had fueled four consecutive daily drops in the S&P 500 index leading up to Wednesday, as questions swirl about returns on AI investments. The benchmark index has fallen nearly 3% so far in November.

    The bar was high heading into Nvidia’s results.

    Adam Turnquist, chief technical strategist for LPL Financial, said the question was not whether the company would beat expectations, “but by how much”.

    “While AI valuations are dominating the news feeds, Nvidia is going about its business in style,” said Matt Britzman, senior equity analyst at Hargreaves Lansdown.

    He said valuations for certain areas of the AI sector “needed to take a breather, but Nvidia is not in that camp”.

    Mr Huang had previously said he expected $500bn in AI chip orders through next year. Investors were looking for details about when the company expects those revenues will come to fruition, and how it plans to fulfill the orders.

    Colette Kress, Nvidia’s chief financial officer, told analysts the company would “probably” be taking more orders on top of the $500bn that had already been announced.

    But she also expressed disappointment about regulatory limits that stymie the company’s ability to export its chips to China, saying the US “must win the support of every developer” including those in China.

    She said Nvidia was “committed to continued engagement” with the American and Chinese governments.

    Earlier Wednesday at the US-Saudi Investment Forum in Washington, Mr Huang joined Elon Musk to announce a massive data centre complex in Saudi Arabia that will have Musk’s AI company, xAI, as its first customer.

    The facility will be outfitted with hundreds of thousands of Nvidia chips.

    The Wall Street Journal reported the US Commerce Department has approved the sale of up to 70,000 advanced AI chips to state-backed companies in Saudi Arabia and the United Arab Emirates, reversing an earlier decision.

    The agreement was brokered following talks between US President Donald Trump and Saudi Arabia’s Crown Prince, Mohammed bin Salman, who visited the White House this week.

    EPA/Shutterstock A sign reads "Nvidia" next to a green logo, in front of a modern building.EPA/Shutterstock

    Last month Nvidia became the first company to be valued at $5tn

    The titans of the technology sector are ramping up their spending on AI, as they rush to reap the benefits of a boom that has pushed stocks to record highs.

    Earnings reports from Meta, Alphabet and Microsoft last month reaffirmed the colossal amounts of money these firms are shelling out for everything from data centres to chips.

    Sundar Pichai, the head of Google’s parent firm Alphabet, told the BBC that while the growth of AI investment had been an “extraordinary moment”, there was some “irrationality” in the current AI boom. His comments came amid other warnings from industry leaders.

    Nvidia, which makes chips that are crucial for AI data centres, is at the heart of a web of deals among key players in the AI space such as OpenAI, Anthropic and xAI.

    The deals have drawn scrutiny for their circular nature, as AI firms increasingly invest in one another. The agreements include Nvidia’s $100bn investment in OpenAI, the firm behind ChatGPT.

    Continue Reading

  • IMF Executive Board Concludes the Fifteenth Periodic Monitoring Report on the Status of Management Implementation Plans in response to Board-Endorsed IEO Recommendations

    IMF Executive Board Concludes the Fifteenth Periodic Monitoring Report on the Status of Management Implementation Plans in response to Board-Endorsed IEO Recommendations

    Washington, DC: The Executive Board of the International Monetary Fund (IMF) concluded the Fifteenth Periodic Monitoring Report (PMR) on the Status of Management Implementation Plans (MIPs) in Response to Board-Endorsed Independent Evaluation Office (IEO) Recommendations. The Board meeting was held on November 12, 2025.

    Since being instituted in January 2007, the PMR has been reporting on the status of implementation of Board-endorsed IEO recommendations. The Fifteenth PMR assessed the progress made over the past year on 48 actions contained in 11 MIPs. These include one new MIP issued in response to an IEO evaluation issued after the Fourteenth PMR.

    The Fifteenth PMR concluded that substantial progress has been made, since the last PMR, with the implementation of management actions despite persistent work pressures. The pace of implementation observed in the Fifteenth PMR, with the closure of 24 actions (or 50 percent implementation rate), was comparable to that of the previous PMR (54 percent implementation rate) and much higher than that of the average of 35 percent per year over the last seven PMR monitoring cycles. Overall progress has been made largely across the board with implementation being particularly faster on actions envisaged in more recent MIPs, such as the MIPs in response to IEO Evaluations on the IMF’s Emergency Response to the COVID-19 Pandemic and IMF Engagement with Small Developing States. Four MIPs—IMF Collaboration with the World Bank on Macro-structural Issues, Behind the Scenes with Data at the IMF, the Role of the IMF as Trusted Advisor and the Board Categorization of Open Actions in Management Implementation Plans—will be retired from the PMR monitoring after the current cycle. The prototype slippages framework, which is anchored in the Fund’s Enterprise Risk Management Framework (ERM) and utilizes ERM tools and processes, has been formally adopted. This framework together with the Framework to Address Open Management Actions in Response to Board-endorsed IEO Recommendations approved in 2019 will further strengthen the evaluation follow-up process.

     

    Executive Board Assessment[1]

    Executive Directors welcomed the opportunity to discuss the Fifteenth Periodic Monitoring Report (PMR) on the Status of Management Implementation Plans (MIPs) in Response to Board Endorsed Independent Evaluation Office (IEO) Recommendations, and broadly endorsed the assessment contained in the PMR.

    Noting persistent workload and budgetary pressures, Directors appreciated the pace of implementation of management actions, comparable to the last PMR and much higher than over the previous seven monitoring cycles. They also welcomed that the action plans are integrated in ongoing workstreams and reviews and acknowledged that the actions implemented are a balance of strategic and operational in nature. Directors noted that since the last PMR, overall progress has been made largely across the board, with implementation being particularly faster on actions envisaged in more recent MIPs and four MIPs to be retired from PMR monitoring after the current cycle. At the same time, some Directors saw scope for a more qualitative, risk based assessment of progress in implementing management actions.

    Directors commented on some areas with completed actions that require continued attention. They broadly echoed the IEO’s concerns about whether the new mission chief and country team tenure metric sufficiently address continuity and tailored advice, particularly for FCS and SDS. Ensuring sufficiently long tenures was emphasized as vital for fostering trust and providing effective, country specific support. Some Directors stressed the need for continued progress in budget reporting to support strategic decision making and prioritization by the Board. A number of other Directors also encouraged continued efforts to enhance collaboration with the World Bank on macro structural issues. A few Directors also asked to revisit when resources allow the decision not to publish indices on CFMs, while a number of others expressed concerns about the retired action on the share of underrepresented nationals and women at senior levels. These Directors underscored the need for follow up across other workstreams to ensure the successful achievement of diversity targets.

    Directors noted the progress made over the past year on overdue actions, and that over half of them are newly overdue. They stressed that continued prioritization of implementation efforts will be key to maintaining the high pace of implementation in an environment characterized by elevated workloads and multiple demands on Fund staff. Directors encouraged timely completion of overdue actions linked to the Capacity Development Guidance Note and the Review of Conditionality. A number of Directors also emphasized the need to ensure that the reformulated overdue action on social protection achieves the objective of effectively guiding the Fund’s involvement in this area.

    Directors welcomed the proposal to implement permanently the prototype slippages framework which is anchored in the Fund’s Enterprise Risk Management (ERM) framework and utilizes ERM tools and processes. The Slippages Framework, together with the Framework to Address Open Management Action in Response to Board endorsed IEO Recommendations approved in 2019, will further strengthen the evaluation follow up process. 

     

    [1] At the conclusion of the discussion, the Managing Director, as Chairman of the Board, summarizes the views of Executive Directors, and this summary is transmitted to the country’s authorities. An explanation of any qualifiers used in summing up can be found here: http://www.IMF.org/external/np/sec/misc/qualifiers.htm.

     

     

    Continue Reading

  • Journal of Medical Internet Research

    Journal of Medical Internet Research

    In recent years, medical crowdfunding platforms enabled by internet technology have emerged and rapidly developed in multiple countries. Such platforms raise medical expenses for individuals from dispersed audiences [], providing an alternative fundraising channel that plays a critical role in reducing out-of-pocket medical costs []. In China, since their rise around 2014, medical crowdfunding platforms have cumulatively raised over 100 billion yuan (approximately US $14.1 billion) for major illness relief, nearly equivalent to the total central government medical assistance allocations from 2018 to 2021 []. Their social influence is deeply embedded in the landscape of medical resource allocation, highlighting the significance of in-depth research on these platforms.

    International academic studies on medical crowdfunding primarily focus on 3 areas. First, factors influencing crowdfunding success. Existing literature systematically explores the roles of multidimensional factors, such as platforms, fundraisers, and donors [], aiming to identify key determinants of campaign success. At the platform level, as the core hub connecting donors and fundraisers, it plays a vital role in resource matching and information transmission []. Studies confirm that basic platform functions like user-friendly interface design and information transparency [], as well as dynamic display elements, such as image quantity and project update frequency [], are significantly correlated with fundraising effectiveness. At the fundraiser level, patient characteristics (age, region, and economic status of residence) [], disease type, treatment stage, and diagnostic certificates [] effectively enhance public attention and donation willingness. Additionally, fundraisers’ narrative strategies and story texts [], along with extensive social network mobilization [], significantly expand project exposure and fundraising scale. From the donor perspective, intrinsic factors, such as altruism, compassion, [], and preferences [] are core motivations for donation behavior. For example, a study suggests that individual donors are more inclined to choose donation amounts with multiple characteristics, such as 5, 10, 20, and 50 []. The group that has experienced donating often shows a stronger willingness to repeat donations due to their higher trust in crowdfunding models.

    Second, while providing critical medical assistance, medical crowdfunding platforms have spawned significant fraud risks, shifting research focus to ethical risks. The model’s low entry barrier, physical distance between fundraisers and donors, and high anonymity in certain links pose substantial integrity challenges []. Take GoFundMe, one of the world’s largest crowdfunding platforms, as an example: it has raised over US $5 billion since 2010, but the ensuing trust crisis has drawn widespread attention []. Research has identified 4 typical fraud categories, such as fabricating or exaggerating one’s own illness, falsifying others’ illnesses, identity impersonation, and misappropriation of donations []. These actions not only directly erode donors’ trust but also undermine public confidence in industry regulatory effectiveness, leading to severe trust crises.

    Third, the complex impacts and negative consequences of medical crowdfunding continue to grow [], becoming a key topic in scholarly discussions. Specifically, while medical crowdfunding offers flexible financial solutions, its potential fairness crisis cannot be ignored []. Studies indicate that its resource allocation mechanism exacerbates social inequality []. Relatively affluent groups with abundant social capital, digital literacy, and media influence leverage platform rules through crafted narratives and social network dissemination to secure more medical support []. In contrast, vulnerable groups, constrained by the digital divide and lacking technical and social mobilization resources, often fail to bring their medical needs to public attention. This differential outcome stems from the inherent limitations of personalized charity. When public medical assistance decisions rely on emotional preferences and subjective values [], resource allocation deviates from institutionalized, universal frameworks and becomes dependent on individual social capital. In the long run, medical crowdfunding may not only fail to bridge health resource gaps but also solidify social stratification in medical accessibility [], systematically impacting the fairness and sustainability of public medical security systems.

    In China, despite attracting public attention and support [] and alleviating patients’ economic burdens, medical crowdfunding platforms face multiple challenges []. First, literature shows a contradiction between commercialization and public welfare. To increase market share, many platforms deploy fundraising consultants for large-scale hospital marketing [], linking business volume directly to consultants’ performance [], which frequently triggers negative publicity about excessive marketing and potential fraud []. Second, systemic loopholes exist, including questionable information authenticity, insufficient transparency, perfunctory review and regulation, and privacy breaches []. These issues not only harm applicants but also erode donors’ basic trust. Finally, scholars emphasize that most platforms do not disclose key information (eg, matching between raised funds and actual needs), raising concerns about irregular fund use and untraceable flows []. The public’s inability to verify fund usage triggers doubts about platform legitimacy and operational purposes [], progressively weakening donation willingness and hindering industry sustainability. Regarding the above issues, some scholars point out that the platform’s predicament stems from a dual reason. From an internal perspective, medical crowdfunding platforms are mostly commercial organizations that pursue profit maximization. They value the number of users, funding, and financing potential, placing public welfare value in a secondary position []. This business orientation gives it a tendency to relax information screening and lower review thresholds to attract users []. At the same time, the platform also has obvious shortcomings in information governance technology and management capabilities []. From the perspective of external factors, China’s relevant legal construction lags behind, and there is a lack of sound legal regulation and effective supervision on the professional ethics and fund flow of fundraising consultants [].

    It is noteworthy that although public skepticism regarding the authenticity of crowdfunding stories primarily arises from the donor’s perspective, this macrolevel climate of trust crisis [] inevitably exacerbates distrust among patients and their families toward the platforms. Within this complex context, fundraising consultants—serving as frontline executors who interact directly with patient families—play a vital role in the operational model of mainstream platforms in China, acting as a critical trust bridge between platforms and potential help-seekers. For internet-based medical crowdfunding—highly dependent on trust []—consultants’ core responsibilities extend beyond explaining platform rules to resolving patient and family doubts through interpersonal interaction, building trust, and mobilizing them to launch campaigns. Therefore, investigating the trust-building strategies used by fundraising consultants is essential for understanding how platforms activate user participation, maintain daily operations, and achieve sustainable development. However, medical crowdfunding research remains in its infancy []. Existing studies, while offering macrolevel insights into operations and institutional flaws, overlook the deep value of microlevel interactions between platforms and patient families [], particularly the lack of inquiry into consultants’ trust-building strategies and their impact on platforms.

    Against this backdrop, this study focuses on China’s medical crowdfunding context, taking trust-building as the entry point to explore consultants’ core trust-building strategies and analyze their impact on platform sustainability. The research questions are: (1) What trust-building strategies do fundraising consultants use in interactions with patients and families? (2) How do these strategies influence the sustainable development of medical crowdfunding platforms? This study first (1) reviews the current research achievements in the field of medical crowdfunding, revealing the contributions and shortcomings of current theoretical research; (2) describes the research methods used in this study; (3) presents the results of data analysis, which are the core strategies for building trust in fundraising consultants. Finally, this study delves into the impact of these strategies on the sustainable development of medical crowdfunding platforms, offering targeted recommendations for optimization and improvement. In summary, by shifting from traditional macrolevel analysis to microlevel interaction scenarios at the service frontline, this study bridges research gaps in trust-building processes to a certain extent and provides theoretical and practical insights for patients and platform managers, promoting industry health and sustainability.

    Design

    A phenomenological qualitative research design involving in-depth semistructured interviews was chosen. Originating in Europe approximately 60 years ago, phenomenological research is defined as “research that seeks to describe the essence of a phenomenon by exploring it from the perspective of those who have experienced it” []. The subjective experiences accumulated by fundraising consultants in their practical work are central to understanding trust construction, and phenomenology is uniquely suited to dissect these experiences from the insiders’ perspective. Thus, qualitative phenomenological research enables researchers to conduct a detailed investigation into the specific strategies used by fundraising consultants to gain the trust of patients and their families, as well as the impact of these strategies on the sustainable development of platforms. The data analysis was based on Colaizzi’s methodology, which has been shown to be rigorous and robust. Colaizzi’s 7-step analytic methodology [] guided the data analysis process by providing the researcher with detailed and sequential steps to improve the reliability and dependability of the results [].

    Participants

    This study used purposeful sampling to obtain a heterogeneous sample, aiming to explore the specific strategies fundraising consultants use to gain the trust of patients and their families, thereby laying a foundation for subsequent in-depth discussions on how these strategies impact platform sustainability. The sample size was determined as follows: after data saturation was reached, an additional 2 fundraising consultants were interviewed. Recruitment was terminated when no new themes emerged.

    All participants were from 4 Chinese internet-based medical crowdfunding platforms. The inclusion criteria were (1) having worked as a fundraising consultant for at least 1 year to ensure sufficient practical experience, (2) engaging in regular direct communication with patients and their families to obtain firsthand experience of trust-building processes, and (3) willingness to participate in in-depth interviews and detailed sharing of work experiences and strategies related to trust-building. The exclusion criteria were (1) individuals who had suspended their role as fundraising consultants in the past 6 months, as prolonged absence from the work context might compromise the timeliness and completeness of their understanding of current trust-building strategies; (2) consultants with language or communication barriers that prevented clear and comprehensive articulation of work experiences to avoid information transmission biases interfering with research analysis; and (3) a diagnosis of severe mental illness.

    Sixteen fundraising consultants aged 25-36 years participated in the study. Most were male (n=9), were 30 years old (n=4), were graduated from junior colleges (n=12), and had 4 years of work experience (n=5; ). To ensure confidentiality, participants’ real names were replaced with case numbers.

    Table 1. Demographic characteristics of fundraising consultants in four Chinese medical crowdfunding platforms (November 2024–March 2025, N=16, phenomenological qualitative study).
    Participant identification Sex Age (years) Education level Work experience (years)
    1 Male 25 Junior College 3
    2 Male 34 Junior College 3
    3 Male 30 Senior High School 2
    4 Female 25 Junior College 4
    5 Male 29 Junior College 4
    6 Female 31 Senior High School 2
    7 Female 31 Junior College 5
    8 Male 29 Junior College 1
    9 Male 36 Junior College 3
    10 Male 30 Junior College 4
    11 Female 27 Senior High School 2
    12 Male 29 Senior High School 4
    13 Female 33 Junior College 4
    14 Female 30 Junior College 5
    15 Male 28 Junior College 2
    16 Female 30 Junior College 3

    Prior to the final recruitment of 16 participants, a total of 22 fundraising consultants were contacted and preliminarily assessed. Among them, 6 were excluded due to failure to meet the inclusion criteria or meeting the exclusion criteria. The reasons for exclusion are as follows: Four fundraising consultants were excluded because they had suspended their relevant work in the past 6 months. Due to their temporary disengagement from the field of medical crowdfunding practice, their understanding of trust-building strategies might differ from the current reality, making it difficult to provide firsthand experience that closely reflects actual practices.

    Two fundraising consultants were excluded due to language expression or communication barriers that prevented them from clearly and accurately describing their work experiences. This study used in-depth semistructured interviews, which highly rely on participants’ ability to articulate detailed implementation of strategies. Communication barriers could compromise the accuracy and reliability of the information collected; thus, these individuals were excluded.

    Data Collection

    Data were collected through individual in-depth semistructured interviews, all of which were conducted jointly by the first and second authors. The interviews took place between November 2024 and March 2025, with each session arranged at a time chosen by the participants and led by the first author. A variety of settings were used, including offices, Chinese restaurants, and parks, resulting in a total of 28 interview sessions with 16 participants. The 28 interview sessions had an average duration of 59 minutes (SD 12).

    Some participants were interviewed multiple times, primarily to address potential information gaps from the initial interviews and to ensure a comprehensive and in-depth exploration of the trust-building strategies used by fundraising consultants. During the actual data collection process, 8 participants were interviewed once while the other 8 underwent multiple interviews. Specifically, 6 participants were interviewed twice, and 2 participants were interviewed 4 times. These participants were identified as having 2 types of information requiring further supplementation: one pertained to overly generalized descriptions of the practical details of certain strategies, and the other involved relatively cautious disclosures of sensitive information. In light of these circumstances, targeted follow-up questions were used in subsequent interviews to gather more concrete details regarding the implementation of trust-building strategies, thereby minimizing the impact of informational ambiguity on the quality of the study.

    At the conclusion of each interview, an open-ended prompt “Do you believe there is any other important information you would like to add?” was used to systematically verify the comprehensiveness and depth of the topics covered. All participants provided similar responses, indicating that “the questions have fully covered the core points.” All interviews were audio-recorded with the written consent of the participants. Verbatim transcription was completed by the first and second authors within 24 hours after each interview, and all personally identifiable information in the transcripts was anonymized. The transcripts were then returned to the participants for review and confirmation of accuracy. No participants withdrew during the interview process, and all interviews were completed in full.

    An interview topic guide was also developed () through a rigorous process. First, a preliminary interview outline was drafted based on an extensive review of existing literature. Relevant literature included studies in the field of medical crowdfunding, particularly those related to trust-building, as well as references on qualitative interview methodologies. Subsequently, the guide was rigorously reviewed by a professor (JH), who optimized the logical flow and wording of the questions and added follow-up prompts, such as “Please describe in detail the implementation process and feedback of trust-building strategies with specific examples” to ensure the depth of data collection. Thereafter, pilot interviews were conducted with 2 fundraising consultants who met the study’s inclusion criteria. The purpose was to check the clarity and comprehensibility of the interview questions and to estimate the time required for formal interviews. Data from the pilot interviews were not included in the final analysis. Based on feedback from these pilot interviews, additional prompts, such as “Can you expand on that?” were incorporated to encourage participants to provide more rich and illustrative examples. On this basis, the final interview guide was confirmed.

    Data Analysis

    Colaizzi’s methodology for analyzing the narratives of each interview involves seven steps: (1) read the transcript to become familiar with and understand the content of the interviews; (2) locate and extract statements related to trust-building strategy from the transcript; (3) formulate meanings; (4) divide all meanings into categories, theme clusters, and themes; (5) define all emergent themes in an exhaustive description; (6) describe the basic structure of the focal phenomena; and (7) return the results to the participants to ensure their accuracy [].

    The first and second authors analyzed each transcript to conduct the initial analysis. During the data analysis process, reflexivity and multiple validation strategies were adopted. For instance, regular research team meetings were held where each researcher was required to present the rationale behind their analysis. In cases of disagreement among researchers, in-depth discussions were conducted until full consensus was reached. This approach helped mitigate analytical biases that might arise from individual perspectives, thereby enhancing the objectivity of the conclusions. To ensure the reliability of the interpretive analysis, member checking was also implemented. A copy of the analysis was sent to 3 randomly selected participants, who were asked whether their interpretation of the data aligned with our analysis. Participants were invited to clarify their viewpoints if they felt misunderstood. Furthermore, 5 fundraising consultants with profiles similar to those of our participants were invited to review the research findings. They unanimously confirmed that the results accurately reflected their trust-building strategies.

    Ethical Considerations

    This study received ethical approval from the Ethics Review Committee of Jiangsu Province Hospital (2025-SR-571). All participants provided written informed consent before interviews, with the consent form clearly explaining the research purpose, procedures, potential risks, rights, and voluntary withdrawal mechanisms. To fully protect participant privacy, personal information, such as names, ages, education levels, and years of work experience was replaced with anonymous codes. All audio recordings were verbatim transcribed within 24 hours, and all identifiers were anonymized in the transcripts. Each participant received monetary compensation after the interview in the form of an electronic gift card valued at 80 Chinese Yuan (approximately US$ 11) as a token of appreciation for their time and valuable insights shared. Moreover, no personally identifiable images, audio, or textual information of participants were used in the paper, supplementary materials, or any public forms of dissemination.

    Overview

    The following three themes emerged from the categorized interview data: (1) establishing initial communication, (2) identifying doubts, and (3) addressing doubts. Each theme is supported by several subthemes, collectively describing the strategies fundraising consultants use to gain the trust of patients and their families ().

    Theme 1: Establishing Initial Communication

    Overview

    All participants agreed that the primary step in building trust is initiating preliminary communication with potential users, as this forms the foundation of trust-based relationships. Among the strategies, using skillful scripted openings to start conversations and conveying empathy and care through sincere expressions emerged as 2 core approaches to bridge the distance between consultants and patients and their families.

    Subtheme 1: Using Scripted Opening Techniques to Initiate Conversations

    Scripted techniques play a crucial role in starting dialogues with potential users. Participants typically approached conversations in a natural, friendly manner, gradually guiding patients and their families to open up and share illness-related information. For instance, the consultant in Case 2 mentioned, when sharing his communication approach, that he progressively guides family members of patients to open up by simulating casual daily conversations:

    Every time I encounter a patient or family member who might need crowdfunding, I sit next to them as casually as visiting a neighbor. I start with everyday topics in a gentle, kind tone—like asking, ‘Is someone in your family hospitalized here? How long have they been here?’ It’s just like chatting with a neighbor… If they’re quiet, I don’t rush. I wait patiently, try a few more questions, and slowly encourage them to talk.
    [Case 2]

    The consultant in Case 6 placed greater emphasis on understanding the other party’s financial pressure. By inquiring about treatment costs and family burdens, they both gathered information and conveyed care:

    I usually first ask about their current financial situation: how much they’ve spent so far, whether the family is under significant financial pressure. Then I talk with them about the illness and future treatment costs. These questions help me understand their financial reality, and more importantly, let them feel I’m genuinely here to solve problems.
    [Case 6]

    Moreover, when the consultant in Case 8 identified that family members of patients had already exhausted all means to borrow money, they would emphasize the practical value of crowdfunding in alleviating debt burdens:

    If I notice the family is already borrowing money everywhere, ie,mphasize how crowdfunding can ease debt pressure. I’ll say, ‘You’ve been borrowing from relatives and friends to treat your family member—it’s really tough. Online crowdfunding could reduce that repayment burden a lot.’
    [Case 8]

    The core of this scripted strategy lies not in persuasive tactics but in building rapport through natural, approachable interactions, guiding patients and families to voluntarily share information and reveal needs. Its essence is to transform the consultant’s professional role into that of a relatable problem-solving partner, making crowdfunding services more accessible to the target group.

    Subtheme 2: Expressing Empathy and Care

    Beyond using scripted openings to initiate interactions, establishing emotional resonance with patients and their families is another critical component of initial communication. When patients and their families face illness and financial strain, they endure immense psychological distress and anxiety, making participants’ expressions of empathy and care particularly significant. The consultant in Case 4 mentioned that expressing understanding can effectively bridge the distance:

    When patients or their families share their experiences, I listen attentively and nod occasionally to show I understand. I also share relatable stories, like the hardships my own relatives faced during illness. This helps them feel truly understood, making them more willing to keep talking.
    [Case 4]

    The consultant in Case 7 demonstrated care through detailed actions:

    I tell them about similar cases I’ve handled, letting them know they’re not alone—many others have endured the same pain and received help through online crowdfunding. For instance, a patient once cried to me that their family was ruined financially from medical bills. I told them about another family that survived desperation through crowdfunding, to give them hope. Afterward, I’d say, ‘See? Others made it through this. You can too. Let’s find a way together.’ I’d also hand them tissues and ask about their kids’ visits or who’s caring for the patient—little details that show I’m not just reciting stories, but truly grasp their distress and care about their situation.
    [Case 7]

    The consultant in Case 1 prioritized providing emotional support over direct promotion when encountering emotionally distressed family members:

    Sometimes I encounter family members crying on hallway benches. I never mention fundraising right away. First, I offer a tissue and ask gently, ‘Ma’am, you’ve been sitting here a while—are you feeling really overwhelmed? My own family dealt with a serious illness before; I know exactly how draining it is…’ Once they calm down a bit, I add, ‘Lots of kind people want to help. Our platform just raised 200,000 yuan for a family with a similar condition—would you like to hear how they did it?’ This approach works better than directly promoting online crowdfunding.
    [Case 1]

    In summary, participants used a range of strategies during initial interactions with potential applicants. These strategies not only effectively encouraged patients and their families to open up and share information but also fostered emotional resonance, creating a communicative atmosphere of trust and understanding that paved the way for introducing medical crowdfunding in subsequent conversations.

    Theme 2: Identifying Doubts

    Overview

    After establishing communication with patients and their families, participants often need to directly address the various doubts raised by them. These doubts reflect the cautious attitude of patients and their families toward medical crowdfunding. Only by accurately identifying such questions and concerns can targeted solutions be better formulated, thereby promoting the establishment of trust relationships. Therefore, identifying doubts constitutes a critical link in the trust-building process. In practice, participants found that the common doubts of patients and their families mainly focus on 3 aspects, including the authenticity of consultants’ identities, the standardization of fund operations, and the security of personal information.

    Subtheme 1: Authenticity of Identity

    Patients and their families often doubted the authenticity of participants’ identities, questioning whether they were credible professionals, which made it difficult to establish trust in a short period. Several participants shared their experiences, revealing the vigilance and specific behaviors of patients and their families.

    The consultant in Case 9 encountered questioning and defensive behaviors:

    Many patients and their families directly ask, ‘Which organization are you from? Are you here to promote something or cheat money?’ One elderly man even took out his phone to record me, saying, ‘I’ll film this in case you’re a bad person—I need evidence.’ Another time, I met a couple: the husband sat silently with a cold expression, while the wife asked a few questions but finally said, ‘We don’t need this. Don’t try to trick us,’ and drove me away.
    [Case 9]

    It is evident that patients and their families generally harbor distrust regarding the authenticity of participants’ identities. As strangers initiating contact, fundraising consultants inherently tend to arouse public suspicion. Moreover, patients’ and families’ past negative experiences with sales pitches or fraud have further deepened their defensive attitudes. Both direct verbal questioning and defensive behaviors reflect their vigilance when interacting with fundraising consultants.

    Subtheme 2: Standardization of Fund Operations

    Patients and their families expressed doubts about the fund operations of medical crowdfunding platforms, which primarily centered on 3 core issues, such as transparency of funding sources, timeliness of fund disbursement, and reasonableness of fees.

    The consultant in Case 5 was frequently asked about specific details regarding the receipt of funds:

    Many patients directly ask me: Where does the crowdfunded money come from? Can we really receive it? How long will it take, and what conditions must be met to get the money?
    [Case 5]

    The consultant in Case 13 shared a typical case illustrating how information opacity exacerbates patients’ anxiety:

    I once met a woman raising funds for her son’s bone marrow transplant. She clutched her phone and repeatedly asked: ‘You say people are donating, but how do I know who the donors are? When will the money be transferred to my bank card?’ Later, I learned she was so anxious about waiting for the funds for surgery that she couldn’t sleep. However, the platform only showed the fundraising progress without explaining the specific disbursement process, leaving her completely uncertain.
    [Case 13]

    Notably, regarding the reasonableness of fees, patients and their families showed particularly strong resistance to platform service charges.

    Many patients ask us: ‘After I launch a crowdfunding campaign, most of the donations come from friends and relatives in my social circle. Since this money is from loved ones, why does your platform charge a fee?’
    [Case 10]

    Subtheme 3: Security of Personal Information

    Patients and their families also expressed strong concerns about the security of their personal information. Since initiating a medical crowdfunding campaign on the platform requires submitting a large amount of sensitive information—such as the patient’s ID number, medical diagnosis, and financial status—patients commonly worried about privacy breaches. Cases shared by participants illustrate their anxiety.

    The consultant in Case 6 observed:

    Many patients abandon the online fundraising application when they reach the step of uploading ID cards and other private information, as they fear the platform might use their information for illegal activities.
    [Case 6]

    The consultant in Case 3 encountered patients who were extremely sensitive about information exposure:

    An elderly person living alone repeatedly asked, ‘Will this information be accessible to others?’ When I mentioned that some details would be made public, they immediately waved their hand and said, ‘I’d rather not raise money than expose all my family’s details.’
    [Case 3]

    Resistance intensified when sensitive information, such as property ownership and financial status, was involved:

    Many patients and their families ask if they can skip providing sensitive details like property ownership, financial assets, or home addresses. They’re truly worried that if this information is made public and accessible to everyone, it might be exploited by criminals.
    [Case 15]

    In summary, the doubts of patients and their families regarding medical crowdfunding platforms are systemic and multidimensional. These concerns essentially stem from their dual needs for resources and security amid hardship. They not only reflect deep-seated issues in medical crowdfunding platforms related to trust-building, information transparency, and the reasonableness of rules but also impose higher demands on participants’ communication strategies and platform operating models. Only by addressing these doubts can the concerns of patients and their families be truly alleviated, fostering the sustainable development of medical crowdfunding platforms.

    Theme 3: Addressing Doubts

    Overview

    In response to the aforementioned questions and concerns from patients and their families, participants typically used strategies to enhance trust in medical crowdfunding platforms. Key approaches included presenting valid credentials, leveraging endorsements from partnerships with medical institutions, showcasing successful cases, and offering additional commitments.

    Subtheme 1: Presenting Valid Credentials

    To quickly alleviate doubts about participants’ identities and the platform, presenting valid credentials emerged as the most direct strategy. The consultant in Case 12 typically presents work credentials immediately:

    If patients or their families are skeptical of my identity, I immediately show them my work Identification. Generally, after they carefully review the information on the Identification—including my name, photo, and affiliated platform—their attitude noticeably softens.
    [Case 12]

    The consultant in Case 5 shared an example of building trust through detailed verification of credentials:

    I once met someone raising funds for their father, who looked at me with obvious wariness. As soon as I started introducing myself, he stepped back. I promptly took out my work Identification, pointed to the name, photo, and platform logo, and said: ‘Look, this is my work credential, and it even has an anti-counterfeit code.’ He took the Identification, checked it repeatedly, and even scanned the QR code twice. After confirming the information was correct, his tone softened: ‘Sorry, there are so many scammers these days. I figured it’s better to be cautious.’
    [Case 5]

    Subtheme 2: Leveraging Endorsements From Medical Institutions

    Another common strategy used by participants to alleviate patients’ and families’ doubts is building trust through partnerships with authoritative institutions, such as hospitals. The consultant in Case 16 would emphasize the platform’s formal collaboration with medical institutions:

    I tell patients and their families that our platform collaborates with many well-known medical institutions. Patients receiving treatment at these hospitals can launch crowdfunding campaigns through our platform… Endorsements from these partner institutions make patients perceive our platform as highly reliable, leading them to choose us for their fundraising needs…Every time a patient says ‘thank you’, I feel that what I do is truly meaningful. For me, this job is not just about making a living—it also feels like doing a good deed.
    [Case 16]

    The consultants in Case 8 and Case 11 enhanced credibility by leveraging physical evidence within hospital settings or authoritative affiliations:

    I take patients and their families to see the promotional posters and cooperation announcements about our platform displayed in hospitals, allowing them to visually confirm our partnership with the hospital.
    [Case 8]

    I explain that I’m visiting on behalf of the hospital to identify patients in financial distress who need fundraising support. People usually lower their guard when they hear I’m commissioned by the hospital.
    [Case 11]

    The consultant in Case 14 even established trust by introducing third-party medical staff:

    For patients or families with high vigilance, I invite them to the hospital’s social work office. Ostensibly, I help arrange for medical social workers to assess their eligibility for hospital-based medical assistance; in reality, this lets them observe my rapport with doctors in white coats, which strengthens their trust… Some patients and families later told me, ‘If the hospital approves of you, we have no reason to worry.’
    [Case 14]

    Subtheme 3: Displaying Successful Cases

    Sharing stories of successful fundraising experiences from patients with similar circumstances is a key strategy to motivate potential users. Participants typically select real cases with comparable illness severity and financial situations, using detailed narratives and visual data to help potential users perceive that they too could resolve part of their funding issues through the medical crowdfunding platform.

    The consultant in Case 1 provided hope to patients by showcasing successful cases of similar medical conditions:

    I show patients successful crowdfunding cases of people with similar illnesses, detailing their fundraising process and the final amount raised. For example, a few days ago, I met a mother whose child needed treatment for congenital heart disease. She was in tears, despairing that she could never afford the surgery. I immediately pulled up cases of patients with the same condition on my phone, showing her how some had raised significant funds through the platform. After seeing them, she seemed to find hope and said she wanted to try…That feeling of helping patients find hope has made me realize that this job is not just about making a living; it’s about making a tangible difference in people’s lives. It makes me feel that my work is truly valuable.
    [Case 1]

    It is evident that when patients witness others with the same illness and hardships regaining hope through the crowdfunding platform and hear firsthand accounts of transformation from despair to hope, the abstract concept of crowdfunding is transformed into tangible hope. This strategy not only alleviates patients’ and families’ concerns but also helps them tangibly recognize the feasibility and effectiveness of medical crowdfunding, thereby encouraging them to proactively seek support from the platform.

    Subtheme 4: Promising Additional Conditions

    Participants strengthen their identification with patients and their families by implementing additional commitment strategies, thereby building trust relationships. For example, committing to protecting personal information security, assisting with fundraising processes, and helping patients apply for economic subsidies.

    The consultant in Case 3 admitted that, even though the platform could not fully guarantee information security, they would still make commitments to gain trust:

    Honestly, our platform can’t fully protect users’ information security—after all, the information is public and accessible to anyone. But to get them to agree to launch the fundraiser, I tell them the platform will protect their personal information, and that I’ll help resolve any issues throughout the process… In short, I do my best to show I’m fully responsible, which makes patients more willing to trust me with their case.
    [Case 3]

    Notably, some participants engaged in inappropriate promising practices. When patients or families requested help with financial subsidy applications, certain participants would promise assistance regardless of eligibility, only to later dismiss the request with “ineligibility” after the crowdfunding campaign was launched. The consultant in Case 10 admitted that due to performance pressure, they would promise financial subsidies that could not actually be delivered:

    When patients ask if I can help them apply for other financial subsidies after fundraising, I usually agree first. In fact, I have a rough idea whether they qualify for medical assistance—even if some don’t, I still promise to help. This makes them feel I’m doing my best, which increases their trust in me…I am aware that this approach is less than ideal, but the pressure from performance assessments is substantial. If I fail to meet the targets, my income will be affected. Therefore, I sometimes resort to this method to secure their trust.
    [Case 10]

    Even more concerning, with particularly difficult-to-communicate patients or families, some participants would deceive them with promises of additional benefits to gain trust, only to later avoid responsibility by claiming application failure.

    If patients or families are hard to communicate with, I first trick them by saying I can help apply for other benefits. Once they launch the crowdfunding, I tell them they’re ineligible or the application failed. As long as the patient eventually initiates the crowdfunding campaign, my work targets are considered fulfilled.
    [Case 14]

    In summary, participants systematically enhanced patients’ and families’ trust in medical crowdfunding platforms through strategies, including presenting valid credentials to verify legitimacy, leveraging hospital partnerships for trust endorsements, sharing successful cases of similar patients, and making supplementary commitments. However, ethical misconduct in commitment strategies—though potentially boosting short-term conversion rates—carries risks of eroding industry credibility, reflecting a deep-seated conflict between commercial logic and service ethics in the crowdfunding ecosystem.

    Principal Findings

    This study found that consultants’ trust-building strategies exhibit a clear binary differentiation feature, characterized by the coexistence of positive and negative strategies. Positive strategies, such as empathy-based communication techniques, presenting valid credentials, leveraging endorsements from medical institution partnerships, and displaying successful cases, are stable and sustainable. They help platforms accumulate long-term reputations and effectively break down patients’ trust barriers. Negative strategies, by contrast, manifest as unethical behaviors, such as false promises and inducements. While these may temporarily improve conversion rates and boost the number of fundraising campaigns launched, they undermine platform credibility to some extent and are detrimental to long-term healthy development.

    These findings can be further elucidated through relevant theories of trust construction. First, the core of trust-building lies in transforming an unfamiliar relationship into interpersonal trust. To achieve this, fundraising consultants strategically leverage patients’ inherent institutional trust in the health care system. Behaviors, such as displaying cooperative agreements with hospitals or guiding patients to medical social work offices, essentially use a trust transfer mechanism to facilitate this conversion. According to this theory, an individual’s institutional trust in authoritative organizations can be transferred across contexts to associated entities; that is, trust can migrate from a trusted object to an unfamiliar one []. In China, doctors and hospitals, as symbols of authority, enjoy a high degree of trust among patients and their families []. This profound institutional trust provides a solid social foundation for trust transfer. By demonstrating their connection to trusted medical institutions, fundraising consultants successfully transfer patients’ institutional trust to themselves (interpersonal trust) and the platform they represent, thereby reducing patients’ cognitive uncertainty and skepticism [].

    Second, behaviors shown by consultants—such as empathetic communication, active listening, sharing personal experiences, offering tissues, and showing care—transcend mere communication techniques and can be viewed as a form of deep emotional labor. By managing their own emotional expressions and adhering to culturally expected patterns of interaction, they strive to establish emotional bonding with patients and families []. This type of emotional labor is particularly crucial within a collectivist culture that emphasizes interpersonal harmony and empathetic interaction, and its effectiveness is deeply rooted in this cultural soil. China has a long tradition of valuing harmony within groups [] and promotes empathic interaction [], stressing the importance of understanding and care in building trust. Within this context, emotional expression surpasses purely professional behavior and becomes a necessary labor within a specific cultural setting. Consequently, the emotional strategies of fundraising consultants exhibit distinct localized characteristics. These strategies not only fulfill the emotional needs of patients and families, making them feel respected and cared for as whole persons rather than just medical cases [], but also lay the groundwork for interpersonal trust, ultimately prompting patients to decide to initiate fundraising.

    In summary, the trust-building process undertaken by fundraising consultants entails transferring institutional trust and cultivating interpersonal relationships. They transfer the patients’ institutional trust in the health care system to themselves and their platform and then nurture and consolidate interpersonal trust through emotional labor. This mechanism not only reveals the internal logic of trust establishment but also provides a profound basis for understanding how positive strategies contribute to the sustainable development of the platform.

    The core of participants’ use of positive strategies lies in influencing the decision-making behaviors of patients and their families by altering their cognitive and emotional states. Specifically, first, at the cognitive level, participants primarily achieved cognitive reconstruction through a trust transfer mechanism. For example, identity-visualizing methods, such as presenting work credentials with anticounterfeit features and displaying partnership announcements with hospitals, allowed patients and their families to visually verify the authenticity of their identities, thereby reducing wariness toward strangers. Second, at the emotional level, participants engaged in emotional labor, such as demonstrating empathy and care and sharing success stories to narrow the emotional distance with patients and their families and evoke hope that their predicament can be resolved. In the context of this study, when patients and their families heard about successful crowdfunding cases, the abstract possibility of crowdfunding success in their minds often transformed into tangible hope. This shift not only helped alleviate their anxiety but also improved their emotional attitudes toward participants and the platform, even enhancing their trust in the effectiveness of crowdfunding, thereby increasing their willingness to proactively launch campaigns on the platform and forming a sustained driving force for platform operations. Scholars have noted that crowdfunding often serves as a resource for both instrumental and emotional social support []. This study further finds that the emotional strategies used by fundraising consultants elevate medical crowdfunding beyond mere fundraising to an interactive process of emotional support. This emotional interaction not only validates previous research conclusions but also reveals a deeper logic. When patients and their families gain hope and emotional satisfaction through participants’ emotional strategies, their proactive crowdfunding behavior becomes a critical link connecting individual trust and platform ecology, ultimately forming the emotional foundation for the sustainable development of medical crowdfunding platforms.

    In addition to positive strategies, some participants also adopted negative strategies when building trust relationships with patients and their families. Their motivations can be attributed to 2 main factors. First, commercialized performance evaluation constitutes a direct driving force. In modern organizational management systems, it has become common for employees to face performance pressure []. Pay for performance, as an important means of motivating employees, has been shown to positively impact work performance []. However, while performance pressure drives desirable outcomes, it also entails risks and uncertainties []. For example, participants in this study tended to adopt unethical behavioral strategies to achieve performance goals. Second, the vulnerability of vulnerable groups is another key factor that cannot be ignored. When patients experience severe illnesses, they not only face uncertainty, anxiety, and fear from deteriorating health or even the threat of death but also bear heavy financial pressure in most families []. This situation plunges them into a state of high vulnerability [], making them urgently dependent on external assistance []. Through experience accumulated over long-term work, participants accurately grasped the vulnerability characteristics and core needs of patient groups and then implemented strategies, such as false inducements to motivate patients and their families to launch medical fundraising. The essence of this behavior is the exploitation of the vulnerability of vulnerable groups, as individuals in helpless situations are more likely to believe seemingly reliable promises. This study not only confirms the vulnerability and dependence of patients as vulnerable groups [] but also reveals how these characteristics are alienated into a tool to achieve commercial goals.

    Through an in-depth analysis of fundraising consultants’ trust-building strategies, this study reveals that their strategic choices are not random but are driven by factors, such as external performance pressure and internal professional identity. Specifically, when consultants face high performance pressure, they tend to adopt negative strategies. This occurs because an excessive emphasis on fundraising targets and commercial returns by platforms effectively marginalizes ethical considerations, prompting consultants to prioritize short-term fundraising goals and consequently choose strategies that may yield immediate results but potentially compromise long-term trust. Conversely, when consultants possess a stronger professional identity or operate within an organizational culture that values service quality and social reputation, they are more inclined to adopt positive strategies. These strategies primarily rely on trust transfer mechanisms, leveraging the established credibility of institutions, such as hospitals, to build sustainable trust relationships.

    Based on these findings, this study proposes that fundraising consultants’ trust-building strategies essentially represent a negotiation and balance between commercial performance and helping ethics. This theoretical perspective connects microlevel individual behaviors with macrolevel institutional and cultural contexts, not only explaining why and when consultants adopt different strategies but also providing an analytical framework for understanding the ethical tensions in the commercialization of public services within the Chinese context.

    It is also noteworthy that this study identified a concerning phenomenon. Patients and their families expressed strong doubts about platform fund operations and information security, but participants’ responses were generally vague. This interaction pattern of avoiding core issues essentially reflects management deficiencies in the platforms’ fund and information security. Existing research indicates that an organization’s internal management capacity is crucial to its development [], and organizations with strong management awareness are more likely to achieve better performance and growth []. In particular, the visibility and security of data in financial transactions [] form the foundation of user trust. Vulnerabilities in these areas not only directly harm users’ property security and privacy rights but may also damage the organization’s trustworthiness and reputation [], exerting a destructive impact on organizational operations and sustainable development.

    Based on the identified negative consultant strategies and platform management deficiencies, this study proposes 3 recommendations to enhance platform sustainability and their role in medical assistance. First, implement comprehensive ethics training for fundraising consultants to improve professionalism. Second, strengthen platform oversight with transparent fund management, robust data security, and strict penalties for misconduct. Third, establish a clear legal framework defining ethical standards, fund handling procedures, and privacy protections to guide industry standardization.

    The novelty of this study lies in its microlevel perspective on fundraising consultants—a key yet understudied actor—and its contextualization within China’s sociocultural environment, enriching trust construction theory in non-Western settings. Theoretically, it extends trust transfer and emotional labor theories to medical crowdfunding, offering new Chinese case evidence. Practically, it provides actionable insights for platform optimization, industry regulation, and patient decision-making, ultimately enhancing service credibility and equity.

    Limitations

    This study has several limitations. First, the inclusion of fundraising consultants from only 4 Chinese platforms limits the generalizability of the findings to other contexts. Second, some interviews were conducted in public settings, such as restaurants and parks, which, despite efforts to select quieter spots, may have influenced participants’ openness, particularly on sensitive topics. Third, the sole focus on consultants—without incorporating views from patients, families, or platform managers—may offer a partial perspective on trust-building and platform operations. Additionally, the absence of quantitative metrics, such as fundraising success rates or patient satisfaction, precludes assessment of the strategies’ practical effectiveness, shifting the emphasis instead to their content and implementation processes. These limitations should be considered when interpreting the results.

    Future Research

    This study highlights several avenues for future inquiry. First, research could explore emotional labor competencies among fundraising consultants to develop culturally grounded support guidelines aligned with China’s collectivist context. Second, examining technical and managerial solutions—such as blockchain applications—to enhance fund traceability and data security represents another critical direction. Third, future work should investigate how performance metrics shape consultants’ ethical decision-making. Finally, incorporating perspectives from patients and families would provide a more comprehensive understanding of trust-building effectiveness and help optimize service delivery.

    Conclusions

    This study uses a phenomenological approach to explore the core strategies used by fundraising consultants to gain the trust of patients and their families in the context of Chinese medical crowdfunding and further analyzes the impact of these strategies on the sustainable development of medical crowdfunding platforms. The findings reveal that consultants’ trust-building strategies exhibit a dualistic character. On one hand, positive strategies, such as empathetic communication techniques, presenting valid credentials, leveraging endorsements from medical institution partnerships, and showcasing successful cases, effectively break down patients’ trust barriers, accumulate long-term reputations for platforms, and generate positive momentum for healthy development. On the other hand, some consultants adopt unethical negative strategies, including false promises and inducements. While these may temporarily increase the number of fundraising campaigns launched, they severely damage platform credibility in the long term and pose hidden risks to sustainable development. In light of these findings, this study proposes several optimization recommendations, such as strengthening professional ethics training for fundraising consultants, improving platform management, supervision, and punishment systems, and accelerating legislation targeting the online medical crowdfunding sector. These measures will not only enhance public trust in platforms but also promote the standardized and sustainable development of medical crowdfunding platforms, ultimately building a reliable social support network for patients in need.

    It is important to clarify that the conclusions of this study are most applicable to contexts that share similar cultural backgrounds and platform operational models with China. Specifically, the boundary conditions can be summarized into 4 key aspects. First, contexts characterized by a collectivist cultural tradition, which emphasizes interpersonal harmony and empathetic interaction, are closely related to the emotional labor strategies adopted by fundraising consultants. Second, the presence of a high level of institutional trust in medical institutions and doctors provides a social foundation for strategies, such as leveraging hospital endorsements. Third, a public medical security system that is still developing, with certain coverage gaps, leads to a higher dependence on crowdfunding among patient families. Fourth, the dominant operational model of medical crowdfunding platforms integrates online and offline approaches, where the offline promotion and involvement of fundraising consultants serve as a core channel for reaching users, rather than a purely online self-initiated model. These factors collectively define the boundary conditions within which the findings of this study are applicable.

    The authors would like to express their gratitude to all participants in this study. Without their generosity in sharing their work experiences and inner thoughts, this research would not have been possible. We also sincerely appreciate the careful guidance from the journal editors and peer reviewers, whose insights have contributed to the refinement and presentation of this study’s findings. No external financial support or grants were received from any public, commercial, or not-for-profit entities for the research, authorship, or publication of this article.

    The datasets generated or analyzed during this study are available from the corresponding author upon request.

    QL contributed to conceptualization, methodology, investigation, formal analysis, and writing—original draft.

    JH was involved in conceptualization, methodology, writing—review and editing, and supervision.

    YT, LD, and TL handled writing—review and editing and validation.

    None declared.

    Edited by Alicia Stone, Amaryllis Mavragani; submitted 24.Jul.2025; peer-reviewed by Ling Ge, Ziqi Peng; final revised version received 05.Oct.2025; accepted 13.Oct.2025; published 19.Nov.2025.

    © Qiong Li, Jianyuan Huang, Yiting Tan, Lina Du, Tifeng Liu. Originally published in the Journal of Medical Internet Research (https://www.jmir.org), 19.Nov.2025.

    This is an open-access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work, first published in the Journal of Medical Internet Research (ISSN 1438-8871), is properly cited. The complete bibliographic information, a link to the original publication on https://www.jmir.org/, as well as this copyright and license information must be included.

    Continue Reading

  • Amkor shares rally in late trade, to work with Nvidia on packaging

    Amkor shares rally in late trade, to work with Nvidia on packaging

    (Reuters) -Shares in Amkor Technology rose more than 8%​ in after-the-bell ‌trading on Wednesday during Nvidia’s conference call after ‌the AI chip leader’s chief financial officer named Amkor among companies it plans to work with on chip packaging.⁠

    Amkor shares were ‌last at $33.58 after hitting a high of $34.‍75 after closing the regular session up 2.4% at $31.43.

    Nvidia CFO Colette ​Kress told investors the company plans ‌to work with Amkor and Siliconware Precision Industries Co Ltd to expand its U.S. manufacturing footprint over the next four years.

    Nvidia last ⁠month said it produced ​its first “Blackwell”​ AI chips at Taiwan Semiconductor Manufacturing Co’s Arizona factory but ‍before those ⁠chips can be sold, they must be shipped to Taiwan for ⁠an advanced packaging process.

    (Reporting by Sinead ‌Carew, Stephen Nellis; Editing ‌by Chris Reese)

    Continue Reading

  • The days of 4% pay rises are behind us – wages are now barely growing faster than inflation | Greg Jericho

    The days of 4% pay rises are behind us – wages are now barely growing faster than inflation | Greg Jericho

    The latest wage figures show no sign of wages growth powering inflation, as the real value of private-sector wages fell in the September quarter.

    Other than inflation, the figures the Reserve Bank of Australia most keeps an eye on are the quarterly wages growth figures. These give us a sense of whether there is so much competition for jobs that employers are offering higher wages and workers can demand higher wages without fear of their hours being cut.

    The RBA likes to think that the current level of unemployment means the job market is still “tight” (a polite way of saying they would like to see more unemployment). They believe there is too much competition for workers, and so wage growth will be strong and drive up prices.

    And yet in the September quarter private-sector wages grew just 0.7%, down from 0.8% in the June quarter and 0.9% in the first three months of this year:

    If the graph does not display click here

    The annual figures also show that wage growth is slowing and the days of wages rising above 4% are behind us.

    If the graph does not display click here

    The slowing figures across the board did, however, bring one moment of unintentional hilarity, when the shadow minister for industrial relations, employment and small business, Tim Wilson, decided this was his chance to show off his economic acumen.

    He quickly put out a media release noting that while private-sector wage growth was slower than this time last year “wages in the public sector rose to 3.8%, up from 3.7% a year earlier”.

    That is true but then, displaying a level of comic ignorance that was missing from parliament during his time out of office, he suggested the Albanese government was to blame. He argued that “Australia’s economy is slowly sinking as the private sector is being outpaced by public spending”.

    Alas for Wilson, had he read the Australian Bureau of Statistics webpage he would have seen the ABS explain that “state government pay rises contributed 82% of public sector wage growth” and that commonwealth public service pay contributed just 0.04 of a percentage point to quarterly public-sector wage growth – or 3.9% of the increase in public-sector wages.

    That is the lowest contribution since 2017:

    If the graph does not display click here

    Also, while public-sector wages outgrew those in the private sector over the past year, that has been very much the exception. Since March 2021, public-sector wages have grown 14.2% compared with 15.2% wage growth in the private sector. The importance of that, however, is that in that same period prices have gone up 21.8% and the cost of living for employee households (which takes into account mortgage repayments) has risen 26.6%:

    skip past newsletter promotion

    If the graph does not display click here

    Wilson may be interested to know that public-sector workers are the ones who have seen their real wages fall the most across the nation since March 2021:

    If the graph does not display click here

    This is the real problem of the wage figures – yes, wages are now barely growing faster than inflation. In the September quarter overall wages fell 0.6% in real terms, which wiped away a lot of the gains since March 2023. Since that time the value of real wages has increased 0.95%, but that still leaves real wages 4.6% lower than they were in March 2021.

    What does that mean? Back then, average full-time earnings was about $90,000 a year. Now those $90,000 have the purchasing power of $85,862 – a loss of $4,138 worth of spending.

    Even worse, because the recovery of real wages is expected to be so slow, if the estimates of the RBA in its most recent Statement on Monetary Policy come to fruition, it will take us until the middle of 2044 to get back to having a wage that has as much purchasing power as in March 2021:

    If the graph does not display click here

    Such a situation is what comes when the policy levers are all geared to treating wage growth as something to prevent – and worries about a “tight labour market” continue to remain even as wage growth slows below that of inflation.

    Greg Jericho is a Guardian columnist and policy director at the Centre for Future Work

    Continue Reading